EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals (AMEX & TSX: NBY, http://www.novabaypharma.com), a clinical stage biopharmaceutical company developing products for the treatment or prevention of a wide range of bacterial, fungal, and viral infections, was featured on KGO-TV, the San Francisco Bay Area’s ABC affiliate. The segment, which aired on Monday, August 4, 2008, featured NovaBay’s key agent, NVC-422, as a new way of killing antibiotic resistant germs spreading through hospitals across the country.
